Still insecure is the Ukrainian healthcare system.

Published Date: 29 Apr 2023

When visiting villages in the country's east that were retaken by Ukrainian forces last autumn, doctor Oleg Marchenko never knows what he will discover. Mines are strewn about, and frequently there are no longer any hospitals.

Read Full News

Latest News

Optimizing DPYD Testing Prior to Fluoropyrimidine Therapy

A PDSA-driven QI project cut DPYD testing turnaround from 16.7 to 12.7 days, though "expedite" order comments alone showed little added benefit.

Syngeneic Modeling of Diet-Driven Liver Cancer

New mouse model of MASLD-driven liver cancer shows sex-based tumor onset and responds to FOG-001, a first-in-class Wnt/β-catenin inhibitor.

VA Dashboards for Clinical Pathway & Genetic Testing Use

New VA dashboards tracking Clinical Pathway adherence helped raise lung cancer testing documentation from 57% to 76% and treatment templates to 42%.

Melanoma Clinical Pearls: 5 Core Principles

Are you up to date on excision margins, sentinel node candidacy, and hereditary risk? Review five critical clinical nuances to refine your approach to melanoma care.

Q&A: Melanoma Clinical Guidance

Do you know the current guidelines for suspicious lesion workups, pathology drivers, and targeted imaging? Explore key diagnostic and management questions shaping modern melanoma care.

Woman’s 3-Year Lip Swelling Reveals Granulomatous Cheilitis

A chronic, painless lip swelling proved diagnostically challenging until histology showed epithelioid granulomas and excluded infection and sarcoidosis.

Todays Updates

Trappsol Cyclo Misses Primary End Point in Phase 3 Trial for Niemann-Pick Disease Type C Isabella Ciccone, MPH

Findings from the phase 3 TransportNPC study showed that Trappsol Cyclo missed the primary end point in Niemann-Pick type C, but subgroup and survival data support planned 2026 NDA.

NeurologyLive® Friday 5 — October 2, 2026 Isabella Ciccone, MPH

Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending October 2, 2026.

Todays Updates

Trappsol Cyclo Misses Primary End Point in Phase 3 Trial for Niemann-Pick Disease Type C Isabella Ciccone, MPH

Findings from the phase 3 TransportNPC study showed that Trappsol Cyclo missed the primary end point in Niemann-Pick type C, but subgroup and survival data support planned 2026 NDA.

NeurologyLive® Friday 5 — October 2, 2026 Isabella Ciccone, MPH

Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending October 2, 2026.

Latest News

A PDSA-driven QI project cut DPYD testing turnaround from 16.7 to 12.7 days, though "expedite" order comments alone showed little added benefit.

New mouse model of MASLD-driven liver cancer shows sex-based tumor onset and responds to FOG-001, a first-in-class Wnt/β-catenin inhibitor.

New VA dashboards tracking Clinical Pathway adherence helped raise lung cancer testing documentation from 57% to 76% and treatment templates to 42%.

Are you up to date on excision margins, sentinel node candidacy, and hereditary risk? Review five critical clinical nuances to refine your approach to melanoma care.

Do you know the current guidelines for suspicious lesion workups, pathology drivers, and targeted imaging? Explore key diagnostic and management questions shaping modern melanoma care.

A chronic, painless lip swelling proved diagnostically challenging until histology showed epithelioid granulomas and excluded infection and sarcoidosis.

News All Time

A Woman on Ruxolitinib Had TB That Mimicked Metastases

A woman receiving ruxolitinib for polycythemia vera developed disseminated tuberculosis despite a negative IGRA, highlighting the limits of screening.

Pediatric Gastroenterology Faces AI Reality Check

From nutrition screening to IBD monitoring, AI shows promise in pediatric gastroenterology — yet experts stress pediatric validation is essential.

Hidradenitis Suppurativa–Associated Squamous Cell Carcinoma

Four cases highlight the aggressive nature of cutaneous squamous cell carcinoma arising in chronic perianal and gluteal hidradenitis suppurativa.

FDA Neurology Digest: August 2026

A monthly snapshot of FDA activity involving therapies used in the prevention, diagnosis, and treatment of neurologic conditions.

Sentinel Lymph Node Biopsy De-Implementation in Women Veterans

This study sought to quantify low-value sentinel lymph node biopsy practices among populations eligible for a de-escalated surgical approach in VA.

Expanding Access to Pediatric Dermatology Through Store-and-Forward Teledermatology

A pediatric dermatology–specific store-and-forward service can enhance access to specialty expertise, support care coordination, and integrate into clinical practice without increasing consultant workload.

Informed-Consent Gaps in Prostate Cancer Genetic Testing

Are oncologists missing key details during genetic testing consent? Dr Maurie Markman reviews new data and why current informed consent falls short.

Kratom: An Emerging Cause of Drug-Induced Hyperpigmentation

Kratom is an increasingly common environmental exposure with potential dermatologic consequences. Learn to recognize its association with hyperpigmentation.
HTTP error: 503HTTP error: 503

Development of a National Hematology Program: Advancing Classical Hematology Care for Veterans

Many classical (nonmalignant) hematologic disorders—including venous thromboembolism (VTE), sickle cell trait, bleeding or clotting disorders, G6PD deficiency, and others—have a propensity to manifest under physical stress or trauma.

Solitary Tender Nodule on the Forearm

A 36-year-old woman presented to the dermatology department with a nodule on the left forearm. What’s your diagnosis?
HTTP error: 503HTTP error: 503

ArteraAI: Current Indications in Prostate Cancer

From localized disease to recurrence, where can ArteraAI add actionable insight for patients with prostate cancer?
HTTP error: 503

Recommended News For You

Recommended Articles For You

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot